Vimta Lab IHnS and now new BO
#VimyaLab had BO of IhnS at 330 level and now again a BO at 450 levels.
Can be added for 34% upside from here for 610.
CMP 461 Qtr Sales growth is flat but ROCE is healthy.
Can be added for 34% upside from here for 610.
CMP 461 Qtr Sales growth is flat but ROCE is healthy.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。